Mining & Metals
The Precision Peptide Company Raises C$2 Million Via LIFE Offering
The Precision Peptide Company (BPC.CN) closed its non-brokered private placement of common shares at C$0.50 apiece under the Listed Issuer Financing Exemption, for C$2 million, through the issuance of 4-million shares, it said in a statement on Wednesday.Proceeds will be used for general working capital needs, to advance its business objectives, fund marketing initiatives and support the procurement of inventory and products, it said.Shares of the company closed unchanged at C$0.495 on Tuesday on the Canadian Securities Exchange.
$BPC.CN
